Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Editas Medicine (EDIT) Capital Leases (2016 - 2018)

Editas Medicine (EDIT) has disclosed Capital Leases for 3 consecutive years, with $32.4 million as the latest value for Q4 2018.

  • Quarterly Capital Leases fell 3.03% to $32.4 million in Q4 2018 from the year-ago period, while the trailing twelve-month figure was $32.4 million through Dec 2018, down 3.03% year-over-year, with the annual reading at $32.4 million for FY2018, 3.03% down from the prior year.
  • Capital Leases for Q4 2018 was $32.4 million at Editas Medicine, down from $32.7 million in the prior quarter.
  • The five-year high for Capital Leases was $35.1 million in Q4 2016, with the low at $11.6 million in Q1 2016.
  • Average Capital Leases over 3 years is $30.6 million, with a median of $33.1 million recorded in 2018.
  • Peak annual rise in Capital Leases hit 191.26% in 2017, while the deepest fall reached 4.74% in 2017.
  • Over 3 years, Capital Leases stood at $35.1 million in 2016, then fell by 4.74% to $33.4 million in 2017, then decreased by 3.03% to $32.4 million in 2018.
  • According to Business Quant data, Capital Leases over the past three periods came in at $32.4 million, $32.7 million, and $32.9 million for Q4 2018, Q3 2018, and Q2 2018 respectively.